Fa. Asimakopoulos et al., THE GENE ENCODING HEMATOPOIETIC-CELL PHOSPHATASE (SHP-1) IS STRUCTURALLY AND TRANSCRIPTIONALLY INTACT IN POLYCYTHEMIA-VERA, Oncogene, 14(10), 1997, pp. 1215-1222
Polycythemia vera (PV) is an acquired clonal disorder characterized by
increased production of mature red cells and growth of erythroid colo
nies in the absence of erythropoietin. Mutation of the erythropoietin
receptor has been demonstrated to cause familial polycythemia, but no
mutations have been found in PV, Moreover, both erythroid and myeloid
progenitors from patients with PV have been reported to be hypersensit
ive to a number of different growth factors. Attention has therefore f
ocused on post-receptor signal transduction pathways, The SHP-1 gene i
s an especially attractive candidate gene. Firstly, SHP-1 binds to and
negatively regulates signalling from the erythropoietin receptor and
is likely to regulate other cytokine receptors in a similar manner, Se
condly, absence of SHP-1 protein in the motheaten mouse is accompanied
by increased sensitivity of hematopoietic progenitors to a number of
cytokines including erythropoietin, Thirdly, familial or sporadic poly
cythemia in man may result from mutations of the SHP-1 binding domain
of the erythropoietin receptor. We have therefore searched for mutatio
ns of the SHP-1 gene in genomic DNA from patients with PV. In this dis
ease the majority of peripheral blood lymphocytes are not part of the
malignant clone and a variable proportion of myeloid cells may arise f
rom normal progenitors. We have therefore chosen to study DNA from pur
ified peripheral blood granulocytes obtained from nine women in whom t
he granulocytes were clonally derived. Southern analysis was used to s
how that the gene was not rearranged and densitometry confirmed the pr
esence of two copies of the gene in each DNA sample. Sequencing of the
entire coding region and all splice junctions revealed no mutations,
Hematopoietic transcription factor binding sites in the SHP-1 promoter
region were intact and the methylation status of the two SHP-1 promot
ers in PV patients was identical to that in three normal controls, Fin
ally, we showed that levels of SHP-1 protein in granulocytes from pati
ents was similar to those from normal controls. These results demonstr
ate that the SHP-1 gene is structurally and transcriptionally intact i
n patients with PV.